152 related articles for article (PubMed ID: 17821828)
1. Antihypertensive therapies.
Smith RE; Ashiya M
Nat Rev Drug Discov; 2007 Aug; 6(8):597-8. PubMed ID: 17821828
[No Abstract] [Full Text] [Related]
2. Aliskiren/valsartan (Valturna) for hypertension.
Med Lett Drugs Ther; 2009 Nov; 51(1326):94-5. PubMed ID: 20224524
[No Abstract] [Full Text] [Related]
3. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
[TBL] [Abstract][Full Text] [Related]
4. Aliskiren/hydrochlorothiazide (Tekturna HCT) for hypertension.
Med Lett Drugs Ther; 2008 Aug; 50(1293):65-6. PubMed ID: 18719523
[No Abstract] [Full Text] [Related]
5. Dual inhibition of the renin system by aliskiren and valsartan.
Oparil S; Yarows SA; Patel S; Zhang J; Satlin A
Lancet; 2007 Sep; 370(9593):1126-7. PubMed ID: 17905160
[No Abstract] [Full Text] [Related]
6. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
Gradman AH; Traub D
Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
[TBL] [Abstract][Full Text] [Related]
7. [New combination of high dosage sartan and 25 mg HCT. Systolic blood pressure lowered by 21 mmHg].
MMW Fortschr Med; 2004 Apr; 146(15):68. PubMed ID: 15373029
[No Abstract] [Full Text] [Related]
8. Aliskiren: a novel renin inhibitor for hypertension.
Parmar DM; Jadav SP
Indian J Physiol Pharmacol; 2007; 51(1):99-101. PubMed ID: 17877301
[No Abstract] [Full Text] [Related]
9. Valsartan plus hydrochlorothiazide for first-line therapy in hypertension.
Lacourcière Y; Poirier L; Samuel R
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1491-501. PubMed ID: 19954310
[TBL] [Abstract][Full Text] [Related]
10. Exforge HCT.
Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
[No Abstract] [Full Text] [Related]
11. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
Scholze J; Müller U
MMW Fortschr Med; 2006 Oct; 148(42):48. PubMed ID: 17621800
[No Abstract] [Full Text] [Related]
12. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
Barrios V; Escobar C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1609-18. PubMed ID: 21090936
[TBL] [Abstract][Full Text] [Related]
13. Aliskiren for hypertension in adults.
Drug Ther Bull; 2008 Oct; 46(10):73-6. PubMed ID: 18832257
[TBL] [Abstract][Full Text] [Related]
14. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
Praxis (Bern 1994); 2004 Oct; 93(42):1748. PubMed ID: 15529964
[No Abstract] [Full Text] [Related]
15. Aliskiren for hypertension: just another option or something truly unique?
Lee S
S D Med; 2007 Oct; 60(10):405-6. PubMed ID: 18019776
[No Abstract] [Full Text] [Related]
16. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
Gottdiener JS
Circulation; 1999 Aug; 100(6):685-6. PubMed ID: 10490345
[No Abstract] [Full Text] [Related]
17. Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapy.
Weinberger MH; Glazer RD; Crikelair NA; Chiang YT
J Hum Hypertens; 2010 Dec; 24(12):823-30. PubMed ID: 20182456
[TBL] [Abstract][Full Text] [Related]
18. Renin inhibition with aliskiren.
Wuerzner G; Azizi M
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):426-30. PubMed ID: 18307734
[TBL] [Abstract][Full Text] [Related]
19. Plasma renin activity testing to guide triple antirenin system drug therapy in a patient with difficult-to-treat hypertension.
Shah S; Coakley C; Hough A; Parra D
Ann Pharmacother; 2014 Feb; 48(2):279-85. PubMed ID: 24259655
[TBL] [Abstract][Full Text] [Related]
20. [Renin inhibitors--new direction in the treatment of arterial hypertension].
Vasiuk IuA; Sadulaeva IA; Iushchuk EN; Trofimenko OS; Chirkov MV; Fedoseeva VS; Kulikov KG
Ter Arkh; 2010; 82(9):53-9. PubMed ID: 21086622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
